|
doxorubicin liposomal
doxorubicin liposomal
information and resources from the National Cancer Institute
Doxil
Accel. Approv. (clinical benefit not established) Treatment of AIDS-related Kaposi's sarcoma in patients with disease that has progressed on prior combination chemotherapy or in patients who are intolerant to such therapy.
Sequus Pharmaceuticals, Inc. Nov 17 1995
Doxil
Accel. Approv. (clinical benefit not established) Treatment of metastatic carcinoma of the ovary in patient with disease that is refractory to both paclitaxel and platinum based regimens
Sequus Pharmaceuticals, Inc. Jun 28 1999
|
|
|
|
|
|
doxorubicin liposomal
-->
|